Medicine
Desmopressin 40 mcg/10 mL injection
Desmopressin 40 mcg/10 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated 2° to 8°C (36° to 46°F).
Key facts
- Active ingredient (INN)
- Desmopressin
- Brand
- Sold under the generic name
- Strength
- 40 mcg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 10 mL and 1 more
- Manufacturers
- Caplin SterilesIndiaNordic Pharma
- Origin register
- US FDA, United States
- Storage
- Store refrigerated 2° to 8°C (36° to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01BA02 Desmopressin
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 January 2016
- Identifiers
- RxCUI 849501, 1723232DailyMed set ID 29df0492-f7ef-47bb-aa67-4ef9e5c2846f, 10b29aa2-274e-4c29-bccd-424bd3761758, 131fd4d8-48ca-4c1f-8165-848dc0a4d511 +1NDC 69918-901, 65145-184Application NDA018938, ANDA219981
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 65145-184-01 | Caplin SterilesIndia | 16 March 2026 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 69918-901-10 | Nordic Pharma | 20 January 2016 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 69918-901-11 | Nordic Pharma | 7 January 2022 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 69918-901-12 | Nordic Pharma | 9 May 2022 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 62756-529-26 | — | 20 February 2014 |
| 1 vial in 1 carton / 10 mL in 1 vial | 62756-529-40 | — | 30 January 2013 |
| 1 vial in 1 carton / 10 mL in 1 vial | 70095-031-01 | — | 20 June 2023 |
| 1 vial in 1 carton / 10 mL in 1 vial | 43598-053-11 | — | 12 September 2022 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-549-01 | — | 20 March 2023 |
| 1 vial in 1 carton / 10 mL in 1 vial | 83148-126-01 | — | 11 August 2026 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 83148-226-01 | — | 30 October 2026 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 72485-524-01 | — | 30 June 2026 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 65219-295-10 | — | 11 September 2023 |
| 1 vial in 1 carton / 10 mL in 1 vial | 71288-441-10 | — | 13 February 2026 |
| 1 vial in 1 carton / 10 mL in 1 vial | 25021-461-10 | — | 15 March 2018 |
| 1 vial in 1 carton / 10 mL in 1 vial | 72843-440-01 | — | 17 September 2020 |
| 1 vial in 1 carton / 10 mL in 1 vial | 39822-6250-1 | — | 22 March 2024 |
| 1 vial in 1 carton / 10 mL in 1 vial | 83634-451-10 | — | 15 October 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 February 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Desmopressin 40 mcg/10 mL injection.
Other strengths and forms of Desmopressin
Clinical summary
Desmopressin is a factor VIII activator indicated for the treatment of nephrogenic diabetes insipidus, among other approved uses. It is available as injection, tablets and nasal solution for intravenous, subcutaneous and oral use. MedsAcross supplies Desmopressin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesmopressinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Desmopressin Acetate prescribing information (Nordic Pharma) · U.S. National Library of Medicine, DailyMed
Need Desmopressin 40 mcg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.